Sartorius Stedim Biotech S.A.
SDMHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $18 | $22 | $28 | $45 |
| - Cash | $1 | $0 | $0 | $0 |
| + Debt | $3 | $4 | $1 | $1 |
| Enterprise Value | $20 | $26 | $29 | $45 |
| Revenue | $3 | $3 | $3 | $3 |
| % Growth | 0.2% | -20.5% | 21% | – |
| Gross Profit | $1 | $1 | $2 | $2 |
| % Margin | 43.4% | 44.4% | 52.5% | 53.8% |
| EBITDA | $1 | $1 | $1 | $1 |
| % Margin | 24.1% | 27.2% | 38.1% | 27.7% |
| Net Income | $0 | $0 | $1 | $0 |
| % Margin | 6.3% | 11.2% | 25.1% | 14.4% |
| EPS Diluted | 1.81 | 3.36 | 9.51 | 4.5 |
| % Growth | -46.1% | -64.7% | 111.3% | – |
| Operating Cash Flow | $1 | $1 | $1 | $1 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |